Improving Nutritional Adequacy of ICU Survivors in a Prospective Interventional Way: the Bright Side Study
NCT ID: NCT06023251
Last Updated: 2024-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2023-10-04
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This enables the investigators to address, within a clinical/scientific context, a recently demonstrated but until now relatively neglected 'dark side' of patient care at UZ Brussel, comparable to limited global evidence : iatrogenic malnutrition of ICU survivors. The use of a newly developed clinical pathway and nutrition strategy (oral, enteral and parenteral) led by a single SPoC (Single Point of Contact) for patients surviving intensive care will have a clear objective: to address the nutritional deficit in all patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Nutrient Absorption in Enterally Fed Post-intensive Care Unit Patients Using Bomb Calorimetry: do the Calories Stick
NCT06923813
Enteral and Parenteral Feeding in Critically Ill Patients
NCT03277300
Achieving nuTritional Target in criticAlly Ill patieNts With iMpairEd gastroiNtesTinal Dysfunction
NCT06510348
Indirect Calorimetry in Patients at Risk of Malnutrition
NCT04500483
Comparison of Continuous Versus Intermittent Enteral Nutrition in Critically Ill Patients.
NCT03573453
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
oral food, enteral nutrition, parenteral nutrition
Clinical Nutrition
Nutritional care plan implementation, including
* A step-up and step-down nutritional protocol guided by caloric and protein ratio
* Monitoring plan including daily nutritional intake assessment by a dietician and (para)medical supervision by a nutrition support pharmacist and nurse concerning dysphagia, refeeding syndrome, electrolytes abnormalities and access issues
* Indirect calorimetry measurements to assess metabolic needs and body impedance analysis to assess body composition on regular time points
* Dedicated and specialized dietician and nurse involvement
* Adaptive communication policy (translating to native language) and culturally appropriate food regimens and artificial nutrition.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinical Nutrition
Nutritional care plan implementation, including
* A step-up and step-down nutritional protocol guided by caloric and protein ratio
* Monitoring plan including daily nutritional intake assessment by a dietician and (para)medical supervision by a nutrition support pharmacist and nurse concerning dysphagia, refeeding syndrome, electrolytes abnormalities and access issues
* Indirect calorimetry measurements to assess metabolic needs and body impedance analysis to assess body composition on regular time points
* Dedicated and specialized dietician and nurse involvement
* Adaptive communication policy (translating to native language) and culturally appropriate food regimens and artificial nutrition.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ICU stay ≥ 7 days
* Ward stay ≥ 3 days
* Nutritional therapy not restricted
* Heterogeneous diseases
Exclusion Criteria
* ICU \< 7 days
* Ward stay \< 3 days
* Advanced Care Planning with impact on nutritional therapy
* Patients with palliative care
* Metabolic derangements such as metabolic diseases
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitair Ziekenhuis Brussel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elisabeth De Waele
Head of Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elisabeth De Waele, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Universitair Ziekenhuis Brussel, Vrije universiteit Brussel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Brussel
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EC-2023-236
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.